PIS
REVBW icon

POM Investment Strategies’s Revelation Biosciences Warrant REVBW Stock Holding History

POM Investment Strategies’s Portfolio REVBW Stock Details REVBW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,005
Closed -$8 – 498
2025
Q4 		$8 Hold
1,005
– – ﹤0.01% 348
2025
Q3 		$11 Hold
1,005
– – ﹤0.01% 201
2025
Q2 		$12 Hold
1,005
– – ﹤0.01% 141
2025
Q1 		$11 Hold
1,005
– – ﹤0.01% 213
2024
Q4 		$7 Hold
1,005
– – ﹤0.01% 341
2024
Q3 		$15 Hold
1,005
– – ﹤0.01% 311
2024
Q2 		$20 Hold
1,005
– – ﹤0.01% 322
2024
Q1 		$27 Hold
1,005
– – ﹤0.01% 250
2023
Q4 		$11 Buy
+1,005
New +$13 ﹤0.01% 231

Other funds holding REVBW

LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
PVI
Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
SIA
Soltis Investment Advisors St. George, Utah $1.59B AUM 23.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
QWM
Quaker Wealth Management Moorestown, New Jersey $344M AUM 15.21% 1-Year Est. Return

POM Investment Strategies's REVBW Position: Q1 2026 in Review

POM Investment Strategies sold out of Revelation Biosciences Warrant (REVBW) in Q1 2026, closing a stake of 1,005 shares — an estimated $8 sold.

POM Investment Strategies first reported a position in REVBW in Q4 2023 and held it in 9 quarters. The position peaked at $27 in Q1 2024. 11 funds tracked by Wall St. Rank hold REVBW as of Q1 2026.

  • POM Investment Strategies reported no remaining Revelation Biosciences Warrant position as of Q1 2026 after selling out during the quarter.
  • POM Investment Strategies sold 1,005 Revelation Biosciences Warrant shares in Q1 2026, an estimated $8.
  • POM Investment Strategies first reported a position in Revelation Biosciences Warrant in Q4 2023 and held it in 9 quarters.
  • POM Investment Strategies's Revelation Biosciences Warrant position peaked at $27 in Q1 2024.
  • 11 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q1 2026.

Based on POM Investment Strategies's 13F filing for Q1 2026, filed 11 May 2026.